{
  "docId": "019de071-753f-7227-aa1d-36a319c59353",
  "docSlug": "7013d0966bfedd0d757b9fa24a480455",
  "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 34 slides",
  "authorId": "astrazeneca",
  "authorName": "AstraZeneca",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-09-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 30,
  "pageCount": 34,
  "prevPage": 29,
  "nextPage": 31,
  "slideType": "appendix_methodology",
  "function": "present_framework",
  "density": "overcrowded",
  "nDataPoints": 4,
  "notes": "The slide uses a process flow diagram to map eligibility criteria to specific patient cohorts.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de071-753f-7227-aa1d-36a319c59353/30",
  "deckHref": "/decks/019de071-753f-7227-aa1d-36a319c59353",
  "deckJsonHref": "/decks/019de071-753f-7227-aa1d-36a319c59353.json",
  "deckAnchorHref": "/decks/019de071-753f-7227-aa1d-36a319c59353#slide-30",
  "components": [
    {
      "bbox": {
        "h": 0.35,
        "w": 0.53,
        "x": 0.11,
        "y": 0.285
      },
      "kind": "diagram",
      "text": "Flow from eligibility criteria to cohorts",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ce646b08-aaeb-496b-bfe3-ad0f592b9da2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.2,
        "x": 0.65,
        "y": 0.29
      },
      "kind": "list",
      "text": "Primary end point: Confirmed ORR by ICR. Secondary end points: DOR, PFS, OS, DCR, Safety. Exploratory: Biomarkers.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dbb9f16d-b4aa-4552-a16b-9735031ba6c3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.25,
        "x": 0.12,
        "y": 0.29
      },
      "kind": "list",
      "text": "Key eligibility criteria: Unresectable/metastatic NSCLC, Relapsed/refractory, Measurable disease, Asymptomatic CNS metastases, ECOG PS 0-1, HER2 mutation",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f71977d2-bc5c-49cc-a863-fb7721fd5ef3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.6,
        "x": 0.12,
        "y": 0.66
      },
      "kind": "paragraph",
      "text": "Data cutoff: May 3, 2021. 91 patients enrolled, 15 on treatment, 76 discontinued.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dcc9847d-fb61-430e-80a2-28a633c00f5a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.95,
        "x": 0.03,
        "y": 0.91
      },
      "kind": "source-note",
      "text": "1. Patients with asymptomatic brain metastases... 30 ECOG PS = Eastern Cooperative Oncology Group performance status...",
      "attrs": {
        "numbered": true
      },
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "61b385c0-a998-429f-8409-b35a555fae82",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.45,
        "x": 0.03,
        "y": 0.06
      },
      "kind": "title",
      "text": "Enhertu: DESTINY-Lung01 trial design",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "48cee95b-7f90-4210-95df-71e9a5dd14dc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.55,
        "x": 0.03,
        "y": 0.13
      },
      "kind": "title",
      "text": "Multi-centre, international, 2-cohort Phase II trial (NCT03505710)",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5d00c26c-aa4a-4577-9908-9391fbdfaafa",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "process",
      "slug": null,
      "matchId": "f41940e9-94a3-4c0a-8078-afcb6ade8510",
      "evidence": "Flowchart showing progression from criteria to cohorts",
      "confidence": 0.8
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}